"Performance" BIOCYTOGEN-B's annual net profit rises 416.4% to RMB 173 million
BIOCYTOGEN-B (02315.HK) announced its full-year results for the year ended December last year, with a revenue of RMB 1.379 billion, an increase of 40.6% year-on-year. The net profit was RMB 173 million, an increase of 416.4% year-on-year; earnings per share were RMB 0.43. No dividend was declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments